Maine 2023-2024 Regular Session

Maine Senate Bill LD1728

Introduced

4/20/23

Refer

4/20/23

Engrossed

5/25/23

Enrolled

5/30/23

Passed

6/6/23

Caption

An Act to Ensure Access to Federally Approved Opioid Overdose-reversing Medication

Companion Bills

No companion bills found.

Previously Filed As

ME HB852

Educational Institutions - Opioid Overdose-Reversing Medications - Policy Requirements (Protecting Our Kids From Overdoses Act)

ME LD710

An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications

ME HB1268

Educational Institutions – Opioid Overdose–Reversing Medications – Policy Requirements

ME SB472

Pupil health: opioid overdose reversal medication.

ME AB915

Pupil health: drug education: opioid overdose training program.

ME AB1915

Pupil health: drug education: opioid overdose training program.

ME AB2998

Opioid overdose reversal medications: pupil administration.

ME HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

ME HB1174

Public schools; authorize to have a supply of FDA-approved opioid reversal agents on premises to counter opioid overdose.

ME HB358

AN ACT relating to opioid overdose reversal agents.

Similar Bills

ME LD710

An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications

CA AB1037

Public health: substance use disorder.

AZ SB1211

Pharmacists; prescribing; naloxone; reporting

CA AB915

Pupil health: drug education: opioid overdose training program.

NJ S3287

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

NJ S899

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and designated persons.

NJ A4244

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and resident assistants.

NJ A4852

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.